1. Home
  2. INTS vs SOGP Comparison

INTS vs SOGP Comparison

Compare INTS & SOGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • SOGP
  • Stock Information
  • Founded
  • INTS 2012
  • SOGP 2010
  • Country
  • INTS United States
  • SOGP Singapore
  • Employees
  • INTS N/A
  • SOGP N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • SOGP
  • Sector
  • INTS Health Care
  • SOGP
  • Exchange
  • INTS Nasdaq
  • SOGP NYSE
  • Market Cap
  • INTS 8.0M
  • SOGP 6.9M
  • IPO Year
  • INTS 2023
  • SOGP 2020
  • Fundamental
  • Price
  • INTS $0.31
  • SOGP $6.07
  • Analyst Decision
  • INTS Strong Buy
  • SOGP
  • Analyst Count
  • INTS 3
  • SOGP 0
  • Target Price
  • INTS $8.50
  • SOGP N/A
  • AVG Volume (30 Days)
  • INTS 2.8M
  • SOGP 2.0M
  • Earning Date
  • INTS 08-07-2025
  • SOGP 07-15-2025
  • Dividend Yield
  • INTS N/A
  • SOGP N/A
  • EPS Growth
  • INTS N/A
  • SOGP N/A
  • EPS
  • INTS N/A
  • SOGP N/A
  • Revenue
  • INTS N/A
  • SOGP $278,363,908.00
  • Revenue This Year
  • INTS N/A
  • SOGP $48.88
  • Revenue Next Year
  • INTS N/A
  • SOGP N/A
  • P/E Ratio
  • INTS N/A
  • SOGP N/A
  • Revenue Growth
  • INTS N/A
  • SOGP N/A
  • 52 Week Low
  • INTS $0.26
  • SOGP $1.18
  • 52 Week High
  • INTS $5.10
  • SOGP $6.20
  • Technical
  • Relative Strength Index (RSI)
  • INTS 38.61
  • SOGP 65.21
  • Support Level
  • INTS $0.26
  • SOGP $4.51
  • Resistance Level
  • INTS $0.31
  • SOGP $6.20
  • Average True Range (ATR)
  • INTS 0.04
  • SOGP 0.80
  • MACD
  • INTS 0.02
  • SOGP 0.11
  • Stochastic Oscillator
  • INTS 40.20
  • SOGP 71.79

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)

Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.

Share on Social Networks: